Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 267 of 267 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/08/18
End: 11/10/21
Due: 11/10/22
Phase: N/A
Priority: Normal
Start: 01/12/17
End: 02/01/22
Due: 02/01/23
Phase: N/A
Priority: Normal
Start: 05/25/17
End: 06/10/20
Due: 06/10/21
A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
Phase: N/A
Priority: Normal
Start: 10/15/18
End: 08/13/19
Due: 08/13/20
Phase: N/A
Priority: Normal
Start: 12/23/22
End: 04/01/27
Due: 04/01/28
Phase: N/A
Priority: Normal
Start: 05/24/20
End: 02/26/21
Due: 02/26/22
Phase: N/A
Priority: Normal
Start: 11/21/18
End: 04/02/24
Due: 04/02/25
Phase: N/A
Priority: Normal
Start: 09/04/20
End: 11/21/24
Due: 11/21/25
Phase: N/A
Priority: Normal
Start: 06/15/11
End: 12/19/18
Due: 12/19/19
Phase: N/A
Priority: Normal
Start: 08/19/21
End: 08/15/24
Due: 08/15/25
Phase: N/A
Priority: Normal
Start: 02/07/20
End: 08/22/23
Due: 08/22/24
Phase: N/A
Priority: Normal
Start: 07/19/22
End: 11/30/27
Due: 11/30/28
Phase: N/A
Priority: Normal
Start: 09/25/19
End: 04/05/22
Due: 04/05/23
Phase: N/A
Priority: Normal
Start: 01/31/23
End: 09/22/24
Due: 09/22/25
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 07/05/22
End: 07/30/26
Due: 07/30/27
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 11/08/17
Due: 11/08/18